| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
A Polymorphism with Lung Cancer Risk1
Etiology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii 96813
Myeloperoxidase, which is released from neutrophils in response to various pulmonary insults including tobacco smoke, is suspected to play a carcinogenic role in the lung. A G-to-A substitution polymorphism in the promoter region of the MPO gene has been suggested in in vitro studies to decrease gene transcription. We tested the association of this polymorphism with lung cancer in a population-based case-control study of 323 cases and 437 controls of Caucasian, Japanese, or Native Hawaiian ancestry in Hawaii. We found a marked difference in the frequency of the variant A allele among Caucasians (26%), Japanese (17%), and Hawaiians (13%). Overall, the variant allele was somewhat less frequent in cases than controls (P = 0.13). Individuals with the A/A genotype were found to be at a 50% decreased risk compared to those with two G alleles (95% confidence interval, 0.2–1.3). Although not statistically significant, this inverse association was suggested in both sexes and two of the three ethnic groups studied. Heterozygotes were at no decreased risk. Further work needs to clarify the functional relevance of the A allele in vivo and to confirm the inverse association of the A/A genotype with lung cancer in large epidemiological studies.
This article has been cited by other articles:
|
|
 |
|
  A. G. Schwartz, G. M. Prysak, C. H. Bock, and M. L. Cote The molecular epidemiology of lung cancer Carcinogenesis, March 1, 2007; 28(3): 507 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zhu, L. Yang, B. Zhou, R. Yu, N. Tang, and B. Wang Myeloperoxidase G-463A polymorphism and the risk of gastric cancer: a case-control study Carcinogenesis, December 1, 2006; 27(12): 2491 - 2496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Knaapen, N. Gungor, R. P. F. Schins, P. J. A. Borm, and F. J. Van Schooten Neutrophils and respiratory tract DNA damage and mutagenesis: a review Mutagenesis, July 1, 2006; 21(4): 225 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Klebanoff Myeloperoxidase: friend and foe J. Leukoc. Biol., May 1, 2005; 77(5): 598 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. B. Ambrosone, J. Ahn, K. K. Singh, H. Rezaishiraz, H. Furberg, C. Sweeney, B. Coles, and A. Trovato Polymorphisms in Genes Related to Oxidative Stress (MPO, MnSOD, CAT) and Survival After Treatment for Breast Cancer Cancer Res., February 1, 2005; 65(3): 1105 - 1111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kawai, H. Morinaga, H. Kondo, N. Miyoshi, Y. Nakamura, K. Uchida, and T. Osawa Endogenous Formation of Novel Halogenated 2'-Deoxycytidine: HYPOHALOUS ACID-MEDIATED DNA MODIFICATION AT THE SITE OF INFLAMMATION J. Biol. Chem., December 3, 2004; 279(49): 51241 - 51249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ahn, M. D. Gammon, R. M. Santella, M. M. Gaudet, J. A. Britton, S. L. Teitelbaum, M. B. Terry, A. I. Neugut, P. D. Josephy, and C. B. Ambrosone Myeloperoxidase Genotype, Fruit and Vegetable Consumption, and Breast Cancer Risk Cancer Res., October 15, 2004; 64(20): 7634 - 7639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-Y. Hsieh, C.-C. Chang, F.-J. Tsai, C.-C. Lin, J.-M. Chen, and C.-H. Tsai Glutathione S-transferase M1*null genotype but not myeloperoxidase promoter G-463A polymorphism is associated with higher susceptibility to endometriosis Mol. Hum. Reprod., October 1, 2004; 10(10): 713 - 717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Hung, P. Boffetta, P. Brennan, C. Malaveille, U. Gelatti, D. Placidi, A. Carta, A. Hautefeuille, and S. Porru Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk Carcinogenesis, June 1, 2004; 25(6): 973 - 978. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Van Schooten, A. W. Boots, A. M. Knaapen, R. W. L. Godschalk, L. M. Maas, P. J. A. Borm, M. Drent, and J. A. Jacobs Myeloperoxidase (MPO) -463G->A Reduces MPO Activity and DNA Adduct Levels in Bronchoalveolar Lavages of Smokers Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 828 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. Schwartz Genetic Predisposition to Lung Cancer Chest, May 1, 2004; 125(5_suppl): 86S - 89S. [Full Text] [PDF]
|
|
|
|
|
|
J. P. Henderson, J. Byun, J. Takeshita, and J. W. Heinecke Phagocytes Produce 5-Chlorouracil and 5-Bromouracil, Two Mutagenic Products of Myeloperoxidase, in Human Inflammatory Tissue J. Biol. Chem., June 20, 2003; 278(26): 23522 - 23528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Katsuda, N. Hamajima, A. Tamakoshi, K. Wakai, K. Matsuo, T. Saito, K. Tajima, and S. Tominaga Helicobacter Pylori Seropositivity and the Myeloperoxidase G-463A Polymorphism in Combination with Interleukin-1B C-31T in Japanese Health Checkup Examinees Jpn. J. Clin. Oncol., April 1, 2003; 33(4): 192 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. E. Caporaso Why Have We Failed to Find the Low Penetrance Genetic Constituents of Common Cancers? Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1544 - 1549. [Full Text] [PDF]
|
|
|
|
|
|
A. Feyler, A. Voho, C. Bouchardy, K. Kuokkanen, P. Dayer, A. Hirvonen, and S. Benhamou Point: Myeloperoxidase -463G -> A Polymorphism and Lung Cancer Risk Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1550 - 1554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-L. Xu, G. Liu, D. P. Miller, W. Zhou, T. J. Lynch, J. C. Wain, L. Su, and D. C. Christiani Counterpoint: The Myeloperoxidase -463G->A Polymorphism Does Not Decrease Lung Cancer Susceptibility in Caucasians Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1555 - 1559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rojas, R. Godschalk, K. Alexandrov, I. Cascorbi, E. Kriek, J. Ostertag, F.-J. Van Schooten, and H. Bartsch Myeloperoxidase - 463A variant reduces benzo[a]pyrene diol epoxide DNA adducts in skin of coal tar treated patients Carcinogenesis, July 1, 2001; 22(7): 1015 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.A. Williams Single nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: why molecular epidemiologists should think about enzyme expression Carcinogenesis, February 1, 2001; 22(2): 209 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.F. Reynolds, M. Hiltunen, M. Pirskanen, A. Mannermaa, S. Helisalmi, M. Lehtovirta, I. Alafuzoff, and a. H. Soininen MPO and APOE{epsilon}4 polymorphisms interact to increase risk for AD in Finnish males Neurology, November 14, 2000; 55(9): 1284 - 1290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Henderson, J. Byun, M. V. Williams, D. M. Mueller, M. L. McCormick, and J. W. Heinecke Production of Brominating Intermediates by Myeloperoxidase. A TRANSHALOGENATION PATHWAY FOR GENERATING MUTAGENIC NUCLEOBASES DURING INFLAMMATION J. Biol. Chem., March 9, 2001; 276(11): 7867 - 7875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Masuda, T. Suzuki, M. D. Friesen, J.-L. Ravanat, J. Cadet, B. Pignatelli, H. Nishino, and H. Ohshima Chlorination of Guanosine and Other Nucleosides by Hypochlorous Acid and Myeloperoxidase of Activated Human Neutrophils. CATALYSIS BY NICOTINE AND TRIMETHYLAMINE J. Biol. Chem., October 26, 2001; 276(44): 40486 - 40496. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
